Emerging Infections
Guidelines
New C. difficile guidelines recommend fecal microbiota transplants
About one-quarter of patients whose infection is treated with vancomycin will likely experience at least one additional episode of infection.
Latest News
FDA issues safety alert for loperamide
Abuse of loperamide tied to opioid epidemic
News from the FDA/CDC
Zika-linked birth defects climbing in U.S. hot spots
Zika-linked birth defects increased in Texas, Florida, and Puerto Rico.
From the Journals
Chikungunya virus goes undetected despite chronic arthritis in 25% of patients after 20 months
The potential mechanisms by which chikungunya may cause chronic arthritis after viral clearing remain unknown.
Conference Coverage
Corynebacterium in the gut can trigger Parkinson’s disease
SAN DIEGO – Can the bacteria be eliminated to prevent the disease?
Conference Coverage
Staph bloodstream infection algorithm shortens treatment course
SAN DIEGO - Average antibiotic duration was shortened by almost 2 days.
Conference Coverage
Post-Ebola syndrome includes neurologic sequelae
A natural history study finds nearly all Ebola survivors experience neurologic sequelae, but symptoms are improving in some patients.
Conference Coverage
Dentist-prescribed antibiotics implicated in community-acquired C. diff
SAN DIEGO – Dental antibiotics help drive community-acquired C. difficile infections.
Conference Coverage
In the reemergence of typhus, the challenge is early diagnosis
SAN DIEGO – Doxycycline is the drug of choice for almost all of the rickettsial infections.
Conference Coverage
IDWeek 2017 opens in San Diego
The IDWeek 2017 symposia, oral abstract sessions, and poster abstract sessions are the highlights.
From the Journals
Bezlotoxumab may lower risk of C. difficile readmissions
A phase 3 drug trial shows promise for high-risk recurrent CDI patients after discharge.